Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
It is typically recommended for patients with a body mass index (BMI) of 30 or higher, or 27 and above if there is an associated weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
Currently, the plan covers GLP-1 drugs for diabetes treatment but not for obesity
Rare but severe side effects include digestive, kidney, and thyroid issues, hair loss, rapid heart rate, vision problems, and mental health concerns
The Medicines and Healthcare products Regulatory Agency (MHRA) provides detailed pharmacokinetic information in the Summary of Product Characteristics for each GLP-1 receptor agonist, which healthcare professionals use to guide prescribing decisions
Intangible Benefits and Quality of Life Value Cost-benefit analysis must also consider intangible benefits that affect quality of life but resist precise quantification
US$ 22.42
US$ 25.14
US$ 22.07
